Laura MORO

Laura MORO is an Associate Professor at the University of Eastern Piedmont Amedeo Avogadro, Department of Pharmaceutical Sciences. Her research focuses on malignant pleural mesothelioma, estrogen receptor biology, epigenetic regulation, and cancer therapy. Key projects include investigating immune checkpoint blockade mechanisms, lipid homeostasis disorders, and ovarian cancer pharmacology.

Her work contributes to UN Sustainable Development Goals related to good health and well-being. Major collaborations include studies on EZH2 inhibition in mesothelioma and lipid storage diseases. She has published extensively on topics like ABHD5 mutations, ALDH1A3 inhibitors, and CDKN2A gene interactions in cancer cells.

Research trends emphasize epigenetic-drug interactions, metabolic pathways in tumors, and gene-drug response relationships. Projects span 2017–2024, addressing translational oncology and personalized medicine.

• Lead PI on Neutral Lipid Storage Disease research (2023–2025)
• Co-Investigator on mesothelioma immune therapy projects (2017–2029)
• Contributed to over 70 peer-reviewed articles, with recent emphasis on high-fat diet epigenetic effects and ABHD5 mutations.

Labs/Teams: Collaborates with Prof. Porta and Pinton on mesothelioma and metabolic research.